How much has Blincyto, Corlanor and Imylgic sold?

We really do work with some idiots! Even if there were no clinical trials in Blin's label patient populations the drug would still not have high revenues. The number of on label patients is tiny. This is about Amgen trying to establish itself as a player in immuno onc. Blin will get label expansions, Bite Technology will expand to other malignancies. Blin was never expected to hit over $100M a year during its first 4 years. Again you prove you know so little of what you speak...it's ok go back to selling supportive care and work your contract. People like you are why Amgen has a terrible reputation in the oncology sales arena, and why no one with experience ever comes to work here. Thanks for making this place the cesspool it is!

 

Your tiny patient pool is going on the 4+ true immuno-oncology trials with CART-T.

No one cares about Bite except Amgen. 24 hour continuous infusion blows just like your daughter

 

You know what blows more than a 24 hour continual infusion? Having no treatment option and certain death. Your calous remarks speak volumes of the toxic culture at Amgen. Blincyto offers a shot at getting to a transplant which could dramatically increase survival for a very sick patient. To mock that exemplifies what is wrong with this company. No culture consultant will ever be able to fix this and that is why Amgen is a joke.

 

There is a treatment option - clinical trials for better immuno oncology drugs. Ones that work even better. Kite, Juno, novartis, and others targetting ALL.

 

......zero point zero...........

 

Yeah because everyone lives near a trial site, or has the means to get there and everyone meets the inclusion criteria. Once again you prove that Amgen is full of idiots who know very little about hematology. Stick to "selling" supportive care...contracts.

 

with 24 hour infusion, the only places that can handle blin are trial sites. DOUCHE BAG!!!!

 

Lyin Ted

 

You are a dummy. So what you are saying is every academic center who treats ALL has a Car-t trial? You are a fucking idiot and continually prove you have no idea what you are talking about.

 

The major ones who have the bulk of the business like MD Anderson, Memorial Sloan Kettering, etc probably have at least 1 if not more Cart-T trials.

Patients don't go to University of Mississippi for ALL.

 

The Q1 earnings call is this week - Thursday afternoon. What are the odds that the company would actually disclose sales numbers for any of the new "blockbuster" products. Or will they continue to hide under the generic tab of "other". Blow past the sales numbers for all the new stuff an hide behind Enbrel, Neulasta, Sensipar - et al. Where the sales numbers are buoyed by the 2x yearly price increase,
These Wall Street dip-shits are afraid to ask what is under the hood.....
Fucking amazing - nice to know that the company has them in their pocket.

 

If these were even 50M dollars each, they would be blockbusters for Amgen!

 

Hey - a year and half later. How is Corlanor doing.
I remember the head marketing guy (The Stutterer) said it would be a $1 Billion in sales by 2019.
Are we on track for that or what?

 

You mean Hank Kessler?

The sales are still listed under "Other" and that's like 5 products for $20M/ qtr...

 

So your saying there is a chance!

 

Yes bumbling idiots can be leaders too